Skip to main content
. 2025 Mar 21;104(12):e41911. doi: 10.1097/MD.0000000000041911

Table 4.

MR analysis and sensitivity analyses for causality from lower urinary stones on 12 blood metabolites.

Name Outcome Metabolites Number of SNPs MR analysis Heterogeneity Pleiotropy MR-PRESSO
Method OR (95% CI) Lower CI Upper CI P IVW MR Egger Intercept P P
Q P Q P
1-methyl-4-imidazoleacetate GCST90199717 Azoles 11 IVW 1.01 0.98 1.03 0.5667 12.01 0.2847 8.45 0.4898 -0.0183 0.0919 0.5793
Mannose GCST90200435 Carbohydrate 11 IVW 1.01 0.98 1.04 0.6419 20.15 0.0279 19.80 0.0192 -0.0059 0.7012 0.6519
1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) GCST90200079 Lipid 11 IVW 1.03 1.00 1.05 0.0238 6.98 0.7274 4.91 0.8423 -0.0148 0.1840 0.5178
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) GCST90200073 Lipid 11 IVW 0.99 0.97 1.02 0.5510 12.72 0.2398 12.49 0.1870 0.0048 0.6941 0.5643
1-palmitoyl-2-oleoyl-GPE (16:0/18:1) GCST90200331 Lipid 11 IVW 1.01 0.98 1.04 0.5139 18.03 0.0544 10.29 0.3279 ‐0.0284 0.0286 0.5286
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) GCST90200065 Lipid 11 IVW 1.03 1.01 1.05 0.0097 6.91 0.7343 6.53 0.6863 ‐0.0061 0.5534 0.5392
Eicosenedioate (C20:1-DC) GCST90200285 Lipid 11 IVW 0.99 0.97 1.01 0.2391 7.92 0.6368 7.90 0.5443 0.0014 0.8926 0.2153
Adenosine 5’-monophosphate (AMP) GCST90200356 Nucleotide 11 IVW 1.00 0.98 1.02 0.8203 3.32 0.9728 3.32 0.9503 0.0004 0.9704 0.7017
Cysteinylglycine GCST90200364 Peptide 11 IVW 0.99 0.97 1.01 0.2056 5.91 0.8229 4.82 0.8499 ‐0.0105 0.3236 0.1307
Urea GCST90200417 Ureas 11 IVW 1.00 0.98 1.02 0.7455 10.01 0.4399 9.75 0.3712 0.0050 0.6372 0.7522
X-17654 GCST90200547 Unknown 11 IVW 1.00 0.98 1.02 0.8169 9.83 0.4553 9.81 0.3662 0.0016 0.8859 0.8201
X-19141 GCST90200711 Unknown 11 IVW 1.01 0.99 1.03 0.5551 8.31 0.5983 8.25 0.5096 0.0026 0.8007 0.5320

CI = confidence interval, IVW = inverse variance weighted, MR = Mendelian randomization, MR-PRESSO = MR-Pleiotropy RESidual sum and outlier, OR = odds ratio, SNPs = single nucleotide polymorphisms.